News

MYC proteins play an important role in many types of cancer. A research team at the University of Würzburg has now succeeded in indirectly influencing these proteins – with clear consequences for the tumor.

An analysis of Maryland ketamine advertisers has suggested that their websites and marketing materials are awash with false and misleading claims about the drug’s addictiveness, side effects and approval status.

Anastrozole is now authorised as a preventative treatment for post-menopausal women at moderate or high risk of breast cancer.

A new targeted drug may offer a new treatment option for patients with blood cancers, including chronic lymphocytic leukemia, showing promise in the first-in-human trials.

Researchers at the University of Freiburg have now been able to prevent the exhaustion caused by CAR-T cell therapy and thus significantly improve the effect of the therapy in a preclinical animal model.

An experimental drug can reduce the toxic changes in tau proteins known to damage neurons in brains with Alzheimer’s disease, researchers report.

Using a technique that has shown promise in targeting cancer tumors, a Duke Health team has found a way to deploy a molecular warhead that can annihilate the bacterium that causes Lyme disease.

A specific microRNA molecule has been identified as a promising starting point for the investigation of new therapies for atherosclerosis.

Researchers at Weill Cornell Medicine have led a phase 1 trial of a new drug that delivers potent radiation therapy directly and specifically to cancer cells in patients with advanced prostate cancer.

Charged, chemically "aggressive" fragments could be the basis for synthesizing new compounds with unreactive elements that could be used for microchips and solar cells.